l carnitine heart damage l-carnitine, a friend or foe for cardiovascular disease? A Mendelian randomization study Carnitine therapy for the treatment
Description
Pucci S, Zonetti MJ, Fisco T, Polidoro C, Bocchinfuso G, Palleschi A et al
Jonathan Picker, Fragile X Program Director, and was updated by Dr
Jan 25 2022;14(3)doi:10.3390/nu14030513
MVP can be stratified into myxomatous degeneration (Barlow), fibroelastic deficiency, and Filamin A-related MVP
